MBOAT7 and metabolic dysfunction-associated steatotic liver disease: Although the subjects in our study were not a population with the highest prevalence rate of NAFLD, they might have additional advantages: (1) the severity of NAFLD seemed to peak in elders; (2) metabolic-associated diseases, such as T2DM and ASCVD, were highly prevalent in the population and facilitate the observation of their correlation with MBOAT7 rs641738 variants.